A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 Diabetes Mellitus and Participants With Non-Alcoholic Fatty Liver Disease
Clinical trial NCT03060538 · COMPLETED
Trial details
- NCT number
- NCT03060538
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-05
- Primary completion
- 2019-12-13
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.